ArticleRheumatology and therapy2024

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.

Andrea Rubbert-Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.